Eurobio Scientific SA
PAR:ALERS

Watchlist Manager
Eurobio Scientific SA Logo
Eurobio Scientific SA
PAR:ALERS
Watchlist
Price: 25.75 EUR Market Closed
Market Cap: 257.6m EUR
Have any thoughts about
Eurobio Scientific SA?
Write Note

Intrinsic Value

The intrinsic value of one ALERS stock under the Base Case scenario is 15.47 EUR. Compared to the current market price of 25.75 EUR, Eurobio Scientific SA is Overvalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALERS Intrinsic Value
15.47 EUR
Overvaluation 40%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Eurobio Scientific SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALERS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALERS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Eurobio Scientific SA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Eurobio Scientific SA

Provide an overview of the primary business activities
of Eurobio Scientific SA.

What unique competitive advantages
does Eurobio Scientific SA hold over its rivals?

What risks and challenges
does Eurobio Scientific SA face in the near future?

Has there been any significant insider trading activity
in Eurobio Scientific SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eurobio Scientific SA.

Provide P/S
for Eurobio Scientific SA.

Provide P/E
for Eurobio Scientific SA.

Provide P/OCF
for Eurobio Scientific SA.

Provide P/FCFE
for Eurobio Scientific SA.

Provide P/B
for Eurobio Scientific SA.

Provide EV/S
for Eurobio Scientific SA.

Provide EV/GP
for Eurobio Scientific SA.

Provide EV/EBITDA
for Eurobio Scientific SA.

Provide EV/EBIT
for Eurobio Scientific SA.

Provide EV/OCF
for Eurobio Scientific SA.

Provide EV/FCFF
for Eurobio Scientific SA.

Provide EV/IC
for Eurobio Scientific SA.

Show me price targets
for Eurobio Scientific SA made by professional analysts.

What are the Revenue projections
for Eurobio Scientific SA?

How accurate were the past Revenue estimates
for Eurobio Scientific SA?

What are the Net Income projections
for Eurobio Scientific SA?

How accurate were the past Net Income estimates
for Eurobio Scientific SA?

What are the EPS projections
for Eurobio Scientific SA?

How accurate were the past EPS estimates
for Eurobio Scientific SA?

What are the EBIT projections
for Eurobio Scientific SA?

How accurate were the past EBIT estimates
for Eurobio Scientific SA?

Compare the revenue forecasts
for Eurobio Scientific SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Eurobio Scientific SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eurobio Scientific SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eurobio Scientific SA compared to its peers.

Compare the P/E ratios
of Eurobio Scientific SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Eurobio Scientific SA with its peers.

Analyze the financial leverage
of Eurobio Scientific SA compared to its main competitors.

Show all profitability ratios
for Eurobio Scientific SA.

Provide ROE
for Eurobio Scientific SA.

Provide ROA
for Eurobio Scientific SA.

Provide ROIC
for Eurobio Scientific SA.

Provide ROCE
for Eurobio Scientific SA.

Provide Gross Margin
for Eurobio Scientific SA.

Provide Operating Margin
for Eurobio Scientific SA.

Provide Net Margin
for Eurobio Scientific SA.

Provide FCF Margin
for Eurobio Scientific SA.

Show all solvency ratios
for Eurobio Scientific SA.

Provide D/E Ratio
for Eurobio Scientific SA.

Provide D/A Ratio
for Eurobio Scientific SA.

Provide Interest Coverage Ratio
for Eurobio Scientific SA.

Provide Altman Z-Score Ratio
for Eurobio Scientific SA.

Provide Quick Ratio
for Eurobio Scientific SA.

Provide Current Ratio
for Eurobio Scientific SA.

Provide Cash Ratio
for Eurobio Scientific SA.

What is the historical Revenue growth
over the last 5 years for Eurobio Scientific SA?

What is the historical Net Income growth
over the last 5 years for Eurobio Scientific SA?

What is the current Free Cash Flow
of Eurobio Scientific SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Eurobio Scientific SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eurobio Scientific SA

Current Assets 143.9m
Cash & Short-Term Investments 89m
Receivables 31.6m
Other Current Assets 23.3m
Non-Current Assets 172.4m
PP&E 12.3m
Intangibles 153.1m
Other Non-Current Assets 7m
Current Liabilities 52.9m
Accounts Payable 13m
Accrued Liabilities 6.1m
Other Current Liabilities 33.8m
Non-Current Liabilities 88.4m
Long-Term Debt 86.2m
Other Non-Current Liabilities 2.2m
Efficiency

Earnings Waterfall
Eurobio Scientific SA

Revenue
144.2m EUR
Cost of Revenue
-76.7m EUR
Gross Profit
67.5m EUR
Operating Expenses
-53.8m EUR
Operating Income
13.7m EUR
Other Expenses
-7.1m EUR
Net Income
6.6m EUR

Free Cash Flow Analysis
Eurobio Scientific SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALERS Profitability Score
Profitability Due Diligence

Eurobio Scientific SA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional 3-Year Average ROE
59/100
Profitability
Score

Eurobio Scientific SA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

ALERS Solvency Score
Solvency Due Diligence

Eurobio Scientific SA's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Negative Net Debt
58/100
Solvency
Score

Eurobio Scientific SA's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALERS Price Targets Summary
Eurobio Scientific SA

Wall Street analysts forecast ALERS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALERS is 30.6 EUR with a low forecast of 30.3 EUR and a high forecast of 31.5 EUR.

Lowest
Price Target
30.3 EUR
18% Upside
Average
Price Target
30.6 EUR
19% Upside
Highest
Price Target
31.5 EUR
22% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALERS?

Click here to dive deeper.

Dividends

Eurobio Scientific SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ALERS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALERS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Eurobio Scientific SA Logo
Eurobio Scientific SA

Country

France

Industry

Biotechnology

Market Cap

281.3m EUR

Dividend Yield

0%

Description

Eurobio-Scientific SA engages in designing, development and commercialization of tests diagnosis in the fields of transplantation, infectious diseases, autoimmunity and oncology, as well as products for research in the field of life sciences. The company is headquartered in Les Ulis, Ile-De-France. The company went IPO on 2005-11-18. The company is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The firm owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. The company consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. The company has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. The company operates through Genbio and Eurobio Capforce Plus.

Contact

ILE-DE-FRANCE
Les Ulis
ZA de Courtaboeuf 7 Avenue de Scandinavie, Les Ulis Cedex
+330153947700.0
www.diaxonhit.com

IPO

2005-11-18

Employees

168

Officers

CEO, Member of Management Board & Chairman
Mr. Denis Fortier
Manager of Finance & IT and CFO
Mr. Olivier Bosc
GM, Member of Management Board & Director
Mr. Jean-Michel Carle Grandmougin
COO and Operations, Affairs Quality & Regulatory
Ms. Cathie Marsais
CCO & Member of Management Board
Mr. Dejan Drljaca
CTO and Director of R&D
Mr. Maarten Penning Ph.D.
Show More
Vice President of Sales & Marketing
Mr. Eric Pryjda
CHRO & Ressources Humaines
Mr. Thomas Moreaux
Chief Business Officer
Mr. Thomas Iff
CMO, COM and Manager of International Product, Infectious & Transplant
Ms. Hanneke Merkens
Show Less

See Also

Discover More
What is the Intrinsic Value of one ALERS stock?

The intrinsic value of one ALERS stock under the Base Case scenario is 15.47 EUR.

Is ALERS stock undervalued or overvalued?

Compared to the current market price of 25.75 EUR, Eurobio Scientific SA is Overvalued by 40%.

Back to Top